Faruqi and Faruqui, LLP Logo
Share this page

OHR Pharmaceutical, Inc. (OHR)

NASDAQ:OHRP

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Ohr Pharmaceutical, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Ohr Pharmaceutical, Inc. (“Ohr” or the “Company”) (NASDAQ:OHRP) of the April 16, 2018 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in Ohr stock or options between June 24, 2014 and January 4, 2018 and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com. 

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased Ohr securities between June 24, 2014 and January 4, 2018 (the “Class Period”). The case, Khanna v. Ohr Pharmaceutical, Inc. et al, No. 18-cv-01284 was filed on February 14, 2018, and has been assigned to Judge Loretta A. Preska.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by failing to disclose that the product Squalamine, the company’s lead product candidate for the treatment of wet-AMD, would not produce vision improvements and was commercially not viable.

Specifically, after years of having touted positive clinical results, on January 5, 2018, the Company announced that topline data from its MAKO study to evaluate the use of Squalamine combination therapy for the treatment of wet-AMD did not meet its primary efficacy endpoint.

After the announcement, Ohr’s share price fell from $2.02 per share on January 4, 2018 to a closing price of $0.38 on January 5, 2018—a $1.64 or an 81.2% drop.

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    OHR Pharmaceutical, Inc. (OHR)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 02/16/2018

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.